dCTP levels are maintained in Plasmodium falciparum subjected to pyrimidine deficiency or excess

Annals of Tropical Medicine and Parasitology

Volumn 91, Issue 6, 1997, Pages 603-609

  Seymour, K K ^a   Yeo, A E T ^a   Rieckmann, K H ^b   Christopherson, R I ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4,6 DIAMINO 1,2 DIHYDRO 2,2 DIMETHYL 1 [3 (2,4,5 TRICHLOROPHENOXY)PROPOXY] 1,3,5 TRIAZINE; 6 THIODIHYDROOROTIC ACID; ADENOSINE TRIPHOSPHATE; ATOVAQUONE; CYCLOGUANIL; CYTIDINE TRIPHOSPHATE; DEOXYADENOSINE TRIPHOSPHATE; DEOXYCYTIDINE TRIPHOSPHATE; DIHYDROOROTASE; DIHYDROOROTATE DEHYDROGENASE; GUANOSINE TRIPHOSPHATE; PYRIMIDINE; PYRIMIDINE ANTAGONIST; RIBONUCLEOTIDE REDUCTASE; THYMIDINE TRIPHOSPHATE; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; HUMAN; HUMAN CELL; NONHUMAN; NORMAL HUMAN; PLASMODIUM FALCIPARUM; PYRIMIDINE SYNTHESIS;

EID: 0030865068     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034983.1997.11813178     Document Type: Article

References (13)

1. CHRISTOPHERSON, R. I., SCHMALZL, K. J. & SHARMA, S. C. (1987). Complete patent specification: Australia 77692/87, Japan 220095/87, U.S.A. 091, 761, South Africa 7/6552, Europe 87307744.0. Enzyme inhibitors.
2. DESJARDINS, R. E., CANFIELD, C. J., HAYNES, J. D. & CHULAY, J. D. (1979). Quantitative assessment of antimalarial activity in vitro by a semi-automated microdilution technique. Antimicrobial Agents and Chemotherapy, 16, 710-718.
3. FRY, M. & PUDNEY, M. (1992). Site of action of antimalarial hydroxynaphthoquinone, 2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphtho quinone (566C80). Biochemical Pharmacology, 43, 1545-1553.
4. HAMMOND, D. J., BURCHELI, J. R. & PUDNEY, M. (1985). Inhibition of pyrimidine biosynthesis de novo in Plasmodium falciparum by 2-(4-t-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinone in vitro. Molecular and Biochemical Parasitology, 14, 97-109.
5. LAMBROS, C. & VANDERBERG, J. P. (1979). Synchronization of Plasmodium falciparum erythrocytic stages in culture. Journal of Parasitology, 65, 418-420.
6. LOOAREESUWAN, S., VIRAVAN, C., WEBSTER, H. K., KYLE, D. E., HUTCHINSON, D. B. & CANFIELD, C. J. (1996). Clinical studies of atovaquone alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. American Journal of Tropical Medicine and Hygiene, 54, 62-66.
7. QUEEN, S. A., VANDERJAGT, D. L. & REYES, P. (1990). In vitro susceptibilities of Plasmodium falciparum to compounds which inhibit nucleotide metabolism. Antimicrobial Agents and Chemotherapy, 34, 1393-1398.
8. REICHARD, P. (1987). Regulation of deoxyribotide synthesis. Biochemistry, 26, 3245-3248.
9. SANT, M. E., LYONS, S. D., PHILLIPS, L. & CHRISTOPHERSON, R. I. (1992). Antifolates induce inhibition of amido phosphoribosyltransferase in leukemia cells. Journal of Biological Chemistry, 267, 11 038-11 045.
10. SEYMOUR, K. K., LYONS, S. D., PHILLIPS, L., RIECKMANN, K. H. & CHRISTOPHERSON, R. I. (1994). Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum. Biochemistry, 33, 5268-5274.
11. THAITHONG, S. & BEALE, G. H. (1981). Resistance of ten Thai isolates of Plasmodium falciparum to chloroquine and pyrimethamine by in vitro tests. Transactions of the Royal Society of Tropical Medicine and Hygiene, 75, 271-273.
12. TRAGER, W. & JENSEN, J. B. (1976). Human malaria parasites in continuous culture. Science, 193, 673-675.
13. YEO, A. E. T., SEYMOUR, K. K., RIECKMANN, K. H. & CHRISTOPHERSON, R. I. (1997). Effects of dual combinations of antifolates and atovaquone or dapsone on nucleotide levels in Plasmodium falciparum. Biochemical Pharmacology, 53, 943-950.